Special Issue "Next-Generation Sequencing for Clinical Application"
Deadline for manuscript submissions: closed (31 December 2016).
Dr. William Chi-shing Cho
Queen Elizabeth Hospital, Hong Kong, China
Interests: cancer biomarker; chinese medicine; diabetes mellitus; evidence-based medicine; genomics; microRNA; molecular diagnostics; nasopharyngeal carcinoma; non-small cell lung cancer; proteomics
After Sanger sequencing, next-generation sequencing has emerged as a powerful tool to uncover the “submerged portion of the iceberg” in various diseases. Many rare and new mutations have been discovered using deep sequencing, which enrich our understanding in clinical genomics. Indeed, there are various high-throughput sequencing platforms available on the market, with sophisticated bioinformatic analysis to reveal the complexity of diseases and living species. We would like to call upon high quality work on this important tool to shape our current understanding and the management of various diseases.
In this Special Issue, we particularly focus on how next-generation sequencing offers solutions to clinical applications, and how can this eventually provide accurate diagnosis and prescription of the right drug and the right treatment to the right patient.
Original papers and review articles that focus on the latest advances of next-generation sequencing are welcomed. The following key areas are covered, but not exclusive:
- New advances in next-generation sequencing
- New diagnoses using next-generation sequencing
- The 1000 genomes project and the international HapMap consortium
- Application of next-generation sequencing for precision medicine
- Next-generation sequencing for tackling the emerging diseases
- Identification of targetable kinase alterations in cancer patients
- Uncovering the disease pathogenesis and drug resistance by next-generation sequencing
- Application of next-generation sequencing to decipher disease contour
- Data analysis in next-generation sequencing
- Bioinformatics in next-generation sequencing
Dr. William Chi-shing Cho
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.